MetaADEDB 2.0 @ LMMD
tibolone
(WZDGZWOAQTVYBX-XOINTXKNSA-N)
Structure
SMILES
C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@H](C)CC2=C1CCC(=O)C2
Type(s)
Approved; Investigational
ATC code(s)
G03CX01
Molecular Formula:
C21H28O2
Molecular Weight:
312.446
Log P:
3.8826
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
1
TPSA:
37.3
CAS Number(s):
5630-53-5
Synonym(s)
1.
tibolone
2.
Boltin
3.
Livial
4.
Liviella
5.
Org OD 14
6.
Org OD14
7.
tibilone
External Link(s)
MeSHC027385
PubChem Compound444008
ChEBI32223
CHEMBLCHEMBL2103774
DrugBankDB09070
DrugCentral2655
IUPHAR/BPS Guide to PHARMACOLOGY9711
KEGGdr:D01639
Therapeutic Target DatabaseD0W3OS
ZINC3812889
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainOFFSIDES
2Abdominal discomfortSIDER
3Abdominal tendernessOFFSIDES
4AcneSIDER
5Acute Coronary SyndromeSIDER
6AgeusiaOFFSIDES
7AlopeciaOFFSIDES
8AmnesiaOFFSIDES
9AmphetaminesOFFSIDES
10ApathyOFFSIDES
11Aphthous StomatitisOFFSIDES
12Arteriosclerosis11256880CTD
13ArthralgiaSIDER
14AscitesOFFSIDES
15Atherosclerosis15780535CTD
16Blood creatine phosphokinase increasedOFFSIDES
17Bone painOFFSIDES
18Breast discomfortSIDER
19Breast tendernessSIDER
20BronchopneumoniaOFFSIDES
21Candidiasis of vaginaOFFSIDES
22Catheter related infectionOFFSIDES
23Cerebrovascular accidentSIDER
24Cervical dysplasiaSIDER
25Cervix carcinomaSIDER
26ChloasmaSIDER
27CholangiolitisOFFSIDES
28ChromaturiaOFFSIDES
29Chronic Obstructive Airway DiseaseOFFSIDES
30ConfabulationOFFSIDES
31Decreased immune responsivenessOFFSIDES
32DementiaSIDER
33DemyelinationOFFSIDES
34Dengue FeverOFFSIDES
35Depressed moodOFFSIDES
36DermatitisSIDER
37DiverticulitisOFFSIDES
38DizzinessOFFSIDES
SIDER
39Drug withdrawal headacheOFFSIDES
40DysgeusiaOFFSIDES
41Endometriosis25673440CTD
OFFSIDES
42Eosinophilic myocarditisOFFSIDES
43Erythema MultiformeSIDER
44Erythema NodosumSIDER
45FatigueOFFSIDES
46Febrile bone marrow aplasiaOFFSIDES
47FormicationOFFSIDES
48Gamma-Glutamyltransferase IncreasedOFFSIDES
49Genital dischargeSIDER
50GlobulinuriaOFFSIDES
51HeadacheSIDER
52HepatitisOFFSIDES
53Hypoaesthesia facialOFFSIDES
54HypophagiaOFFSIDES
55HypoxiaOFFSIDES
56Iatrogenic injuryOFFSIDES
57Infusion site mobility decreasedOFFSIDES
58Intestinal PerforationOFFSIDES
59LethargyOFFSIDES
60Medical device complicationOFFSIDES
61Micturition frequency decreasedOFFSIDES
62Multiple MyelomaOFFSIDES
63Musculoskeletal discomfortSIDER
64MyalgiaSIDER
65Myocardial InfarctionSIDER
66Myocardial Ischemia11791085CTD
67NauseaOFFSIDES
68Nipple painSIDER
69Obsessive thoughtsOFFSIDES
70Ocular vascular disorderOFFSIDES
71Oropharyngeal painOFFSIDES
72Ossicle disorderOFFSIDES
73Osteoporosis, Postmenopausal11991445CTD
74Osteoporosis11791085CTD
75PainOFFSIDES
76Pelvic PainSIDER
77Pelvic venous thrombosisSIDER
78Pericardial effusionOFFSIDES
79Porphyria non-acuteOFFSIDES
80Post procedural painOFFSIDES
81PruritusSIDER
82PseudoporphyriaOFFSIDES
83Pulmonary EmbolismSIDER
84SalpingitisOFFSIDES
85Septic arthritis staphylococcalOFFSIDES
86Sleep-related eating disorderOFFSIDES
87Staphylococcal osteomyelitisOFFSIDES
88Tinea PedisOFFSIDES
89TympanosclerosisOFFSIDES
90Vaginal DischargeSIDER
91Vaginal mycosisSIDER
92Vascular purpuraSIDER
93Venous ThromboembolismSIDER
94Viral myocarditisOFFSIDES
95Visual ImpairmentSIDER
96Visual disturbanceOFFSIDES
SIDER
97Vulvovaginal mycotic infectionSIDER
98VulvovaginitisSIDER
99Weight Gain11991445CTD
OFFSIDES
100Wound InfectionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.